finance.yahoo.com ·
Doximity Stock Dives Q4 Earnings
Topic context
This topic has been covered 249706 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedDoximity (DOCS) is a digital platform for healthcare professionals. The earnings miss and below-consensus guidance indicate slowing revenue growth and margin pressure. The commercial mechanism is a demand_spike fade: post-pandemic telehealth usage normalization reduces platform subscription and advertising revenue. No input scarcity or supply chain disruption; the impact is company-specific and sector-wide for health-tech platforms. Weak commercial mechanism — primarily equity valuation adjustment with no direct commodity or supply chain effect.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Doximity Q4 FY2026 revenue $145.4M vs estimate $144.08M (beat).
- Adjusted EPS $0.26 vs $0.28 estimate (miss).
- Q1 FY2027 revenue guidance $151-152M vs $153.7M estimate.
- FY2027 revenue guidance $664-676M vs $697.6M estimate.
- Stock fell 19.58% after-hours to $18.81.
Health-tech platforms face 24-48h valuation markdown on Doximity's guidance miss; subscription and ad revenue growth deceleration.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- GLOBAL_TECHmid
- GLOBAL_TECHshort
Related stories
finance.yahoo.com
Manulife Financial Q1 Earnings Call
finance.yahoo.com
Nextera Dominion Energy Merger Create
finance.yahoo.com
Ascend Wellness Q1 Earnings Call
finance.yahoo.com
Eurodry Edry Q1 2026 Earnings
moneycontrol.com